Targeted Genetics Subject Dies in Trial
“We are deeply saddened by the death of an individual enrolled in our clinical trial. The welfare of the trial participants is always our foremost consideration and concern”
Targeted Genetics Corp. said Thursday a patient died in its early-to-midstage study of a potential inflammatory arthritis drug. via Forbes
Join the discussion below, or Read more at Forbes.
#1 Aug 15, 2007
This company needs SCRUTINY fast!
Add your comments below
Copyright © 2018 Topix LLC